• Country
    Clear
  • Compatibility Level
    Clear
  • Type
  • Thematic
  • Jurisdiction

  • GB
  • Not yet registered

  • more_vert
  • more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • more_vert
  • more_vert
  • more_vert
  • more_vert
  • Record does not exist anymore: Environmental Information Data Centre . The record with identifier content 10.25504/FAIRsharing.9raft1 was invalid.Records previously linked: [3418, 3419, 3424, 3427, 3429, 3453]. Organisations previously linked: [2090, 461]. Licences previously linked: [115, 1056].

    more_vert
  • The IPD-MHC Database provides a centralised repository for sequences of the Major Histocompatibility Complex (MHC) from a number of different species. Through a number of international collaborations IPD is able to provide the MHC sequences of different species. The sequences provided by each group are curated by experts in the field and then submitted to the central database.

    more_vert
  • chevron_left
  • 3
  • 4
  • 5
  • 6
  • 7
  • chevron_right